Lance D. Miller

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Supplementary figure 5 from Targeting NTRK1 Enhances Immune Checkpoint Inhibitor Efficacy in NTRK1 Wild-Type Non–Small Cell Lung Cancer

  2026-06-17

• Supplementary figure 2 from Targeting NTRK1 Enhances Immune Checkpoint Inhibitor Efficacy in NTRK1 Wild-Type Non–Small Cell Lung Cancer

  2026-06-17

• Supplementary figure 1 from Targeting NTRK1 Enhances Immune Checkpoint Inhibitor Efficacy in NTRK1 Wild-Type Non–Small Cell Lung Cancer

  2026-06-17

• Supplementary figure 6 from Targeting NTRK1 Enhances Immune Checkpoint Inhibitor Efficacy in NTRK1 Wild-Type Non–Small Cell Lung Cancer

  2026-06-17

• Supplementary figure 3 from Targeting NTRK1 Enhances Immune Checkpoint Inhibitor Efficacy in NTRK1 Wild-Type Non–Small Cell Lung Cancer

  2026-06-17

• Supplementary figure 4 from Targeting NTRK1 Enhances Immune Checkpoint Inhibitor Efficacy in NTRK1 Wild-Type Non–Small Cell Lung Cancer

  2026-06-17

• Abstract 4854: Mutational profiling of patient tumor organoids for clinical variable association and markers of therapeutic response in mucinous appendiceal cancers

  Cancer Research · 2026-04-03

• Distinct transcriptomic signatures in non-hispanic black AML patients with NPM1 mutations reveal potential drivers of poor prognosis

  Blood · 2025-11-03

• Leukocyte-intrinsic ER stress responses contribute to chemotherapy-induced peripheral neuropathy

  Science Translational Medicine · 2025-10-29 · 7 citations

• Treatment of glioblastoma with tumor-specific amplitude-modulated radiofrequency electromagnetic fields

  Oncotarget · 2025-10-13

• The Genomic Topography of Appendiceal Cancers: Our Current Understanding, Clinical Perspectives, and Future Directions

  Cancers · 2025-10-09 · 1 citations

• Abstract 921: SOX11-mediated antigen presentation suppression: A mechanism of immune evasion in triple-negative breast cancer

  Cancer Research · 2025-04-21

• Abstract 5565: Dysfunction in ATP-binding cassette 1 (ABCA1): a driver of intracellular cholesterol accumulation and potential therapeutic vulnerability of bowel cancers

  Cancer Research · 2025-04-21

• Abstract A012: Mutation analysis of SCLC patients with distant metastases

  Cancer Research · 2025-03-11

• Intrinsic subtype and immunity score in identification of triple-negative breast cancer at low risk

  The Breast · 2025-01-24

• Supplementary figure 5 from Targeting NTRK1 Enhances Immune Checkpoint Inhibitor Efficacy in NTRK1 Wild-Type Non–Small Cell Lung CancerPreprint

  2024-12-02

• Supplementary Table 1-16 from Targeting NTRK1 Enhances Immune Checkpoint Inhibitor Efficacy in NTRK1 Wild-Type Non–Small Cell Lung Cancer

  2024-12-02

• Supplementary figure 6 from Targeting NTRK1 Enhances Immune Checkpoint Inhibitor Efficacy in NTRK1 Wild-Type Non–Small Cell Lung CancerPreprint

  2024-12-02

• Supplementary figure 2 from Targeting NTRK1 Enhances Immune Checkpoint Inhibitor Efficacy in NTRK1 Wild-Type Non–Small Cell Lung CancerPreprint

  2024-12-02

• Supplementary figure 3 from Targeting NTRK1 Enhances Immune Checkpoint Inhibitor Efficacy in NTRK1 Wild-Type Non–Small Cell Lung CancerPreprint

  2024-12-02